- Home
- CBZ vs AMRX Comparison
CBZ vs AMRX Comparison
Compare CBZ & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBZ
- AMRX
- Stock Information
- Founded
- CBZ 1987
- AMRX 2002
- Country
- CBZ United States
- AMRX United States
- Employees
- CBZ N/A
- AMRX N/A
- Industry
- CBZ Business Services
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- CBZ Consumer Discretionary
- AMRX Health Care
- Exchange
- CBZ Nasdaq
- AMRX Nasdaq
- Market Cap
- CBZ 3.5B
- AMRX 2.9B
- IPO Year
- CBZ N/A
- AMRX N/A
- Fundamental
- Price
- CBZ $54.91
- AMRX $9.81
- Analyst Decision
- CBZ
- AMRX Strong Buy
- Analyst Count
- CBZ 0
- AMRX 4
- Target Price
- CBZ N/A
- AMRX $12.00
- AVG Volume (30 Days)
- CBZ 579.9K
- AMRX 1.5M
- Earning Date
- CBZ 10-28-2025
- AMRX 11-07-2025
- Dividend Yield
- CBZ N/A
- AMRX N/A
- EPS Growth
- CBZ N/A
- AMRX N/A
- EPS
- CBZ 1.84
- AMRX 0.01
- Revenue
- CBZ $2,420,673,000.00
- AMRX $2,852,914,000.00
- Revenue This Year
- CBZ $56.99
- AMRX $9.56
- Revenue Next Year
- CBZ $5.51
- AMRX $6.27
- P/E Ratio
- CBZ $30.84
- AMRX $903.77
- Revenue Growth
- CBZ 46.49
- AMRX 9.81
- 52 Week Low
- CBZ $53.92
- AMRX $6.69
- 52 Week High
- CBZ $90.13
- AMRX $10.34
- Technical
- Relative Strength Index (RSI)
- CBZ 34.15
- AMRX 60.91
- Support Level
- CBZ $53.92
- AMRX $9.57
- Resistance Level
- CBZ $57.51
- AMRX $10.34
- Average True Range (ATR)
- CBZ 2.06
- AMRX 0.25
- MACD
- CBZ -0.29
- AMRX -0.04
- Stochastic Oscillator
- CBZ 9.02
- AMRX 48.04
About CBZ CBIZ Inc.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.